Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shatterproof is a prominent national non-profit organization dedicated to reversing the addiction crisis in the United States. Founded in 2013, the organization focuses on transforming the addiction treatment system through advocacy, education, and the implementation of evidence-based standards. Shatterproof developed the ATLAS platform, a comprehensive resource that helps individuals and families find high-quality addiction treatment facilities based on clinical quality measures. The organization also works extensively on public policy to increase access to life-saving medications and to reduce the social stigma surrounding substance use disorders. By bridging the gap between research and practice, Shatterproof aims to ensure that every American has access to effective, science-based addiction care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shatterproof.